Alexey Aleshin
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 70
- Oncology top 5%
- Cancer Cells and Metastasis 15
- Colorectal Cancer Treatments and Studies 15
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 6
-
- Genetic factors in colorectal cancer 35
-
- Lung Cancer Treatments and Mutations 6
- Genetics top 10%
-
- Acute Myeloid Leukemia Research 8
- Co-authors
- Richard S. FinnDennis J. SlamonMinetta C. LiuStacey A. CohenPaul R. BillingsHimanshu SethiShruti SharmaMeenakshi Malhotra
- Journals
- Nature (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (29 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Alexey Aleshin
87 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 828
- Oncology 863
- Pathology and Forensic Medicine 341
- Pulmonary and Respiratory Medicine 583
- Genetics 94
Countries citing papers authored by Alexey Aleshin
This map shows the geographic impact of Alexey Aleshin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexey Aleshin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexey Aleshin more than expected).
Fields of papers citing papers by Alexey Aleshin
This network shows the impact of papers produced by Alexey Aleshin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexey Aleshin. The network helps show where Alexey Aleshin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexey Aleshin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 61 | |
| 4 | 2023 | 33 | |
| 5 | 2023 | 26 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 48 | |
| 9 | 2022 | 36 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 33 | |
| 12 | 2021 | 92 | |
| 13 | 2021 | 33 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2020 | 7 | |
| 19 | 2010 | 19 | |
| 20 | SNS-032 is a potent and selective inhibitor of CDK2, 7 and 9 and induces cell death by inhibiting cell cycle progression and the expression of antiapoptotic proteins | 2006 | 7 |
About Alexey Aleshin
Alexey Aleshin is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (70 papers), Genetic factors in colorectal cancer (35 papers), Cancer Cells and Metastasis (15 papers), Colorectal Cancer Treatments and Studies (15 papers), Acute Myeloid Leukemia Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (828 citations), Oncology (863 citations) and Pathology and Forensic Medicine (341 citations). Alexey Aleshin has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Richard S. Finn, Dennis J. Slamon, Minetta C. Liu, Stacey A. Cohen, Paul R. Billings, Himanshu Sethi, Shruti Sharma, Meenakshi Malhotra, Pashtoon Murtaza Kasi and Ekaterina Kalashnikova. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.